Medical Device Network on MSN
FDA approves Medtronic’s urinary incontinence treatment device
Implantation of the device is minimally invasive, requiring no sedation or imaging, and is conducted near the ankle.
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.
In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...
Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting and low-maintenance therapy.
In November, the Food and Drug Administration (FDA) approved r-SNM, the first rechargeable sacral nerve stimulator cleared for full-body MRI scans, and sales results from the initial launch were ...
Bladder leakage is a problem for 60-percent of women. These kinds of incontinence issues can be a big problem, and significantly impact quality of life. Sarah Avrech is a mom of three. She started ...
MedPage Today on MSN
FDA Approves Nerve Stimulator for Bladder Control
Inserted near the ankle in a minimally invasive procedure, the device generates low-level electronic impulses that stimulate the tibial nerve to restore bladder-brain communication. The device is the ...
Kathy Boehm shows where the charger is placed to recharge her implant. The charger can be in a belt or tucked inside her pants. Dr. Tarek Garas Dr. Lindsey Hahn Locating the nearest bathroom when she ...
Medtronic (NYSE: MDT) today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.
CINCINNATI (WKRC) - A groundbreaking device that functions like a pacemaker for the bladder was offering hope to those suffering from overactive bladder, a condition marked by urinary urgency, ...
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...
Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results